Redhill Biopharma
RDHL----
Redhill Biopharma (RDHL)
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercia...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Redhill Biopharma Analyst Rating
View MoreForecast & Rating
Feb 17, 2023Price forecast
$1000.00149555.79%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 2 at 07:41 AM
RedHill Biopharma posts corporate presentation outlining Talicia commercialization and late-stage GI, infectious disease, oncology pipeline
- benzinga_article · Jul 1 at 07:05 AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- PUBT · Jul 1 at 06:03 AM
RedHill Biopharma delays annual shareholder meeting to Aug. 6 to add proposal to proxy materials
- PUBT · Jun 29 at 06:01 AM
RedHill Biopharma ups maximum size of H.C. Wainwright-led ATM ADS offering
- Tip Ranks · Jun 25 at 06:32 AM
RedHill Biopharma Sets July 28, 2026 AGM to Vote on Board, Auditor and Chairman-CEO Role
- prnewswire · Jun 22 at 03:10 PM
16:10 ETRedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
